Cerebral Aneurysms Global Clinical Trials Review, H2, 2011

GlobalData, November 2011, Pages: 53

Cerebral Aneurysms Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H2, 2011" provides data on the Cerebral Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Aneurysms. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebral Aneurysms. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Cerebral Aneurysms Clinical Trials, Trial Designs, Trial Designs, Subjects Recruited, Unaccomplished Trials of Cerebral Aneurysms, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Cerebral Aneurysms
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Seoul National University Bundang Hospital
Clinical Trial Overview of Seoul National University Bundang Hospital
Second Military Medical University
Clinical Trial Overview of Second Military Medical University
Shanghai Jiao Tong University
Clinical Trial Overview of Shanghai Jiao Tong University
University of Manitoba
Clinical Trial Overview of University of Manitoba
University of Virginia
Clinical Trial Overview of University of Virginia
Medical University of South Carolina
Clinical Trial Overview of Medical University of South Carolina
Kyoto University
Clinical Trial Overview of Kyoto University
Kuopio University Hospital
Clinical Trial Overview of Kuopio University Hospital
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
Five Key Clinical Profiles
Appendix Abbreviations BRIC: Brazil, Russia, India and China MRA: Magnetic Resonance Angiography
Definitions PHASE I TRIALS: Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific,Top Countries, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Countries, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, BRIC Countries, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, G7 Countries, 2011-
Cerebral Aneurysms Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, E7 Countries, 2011-
Cerebral Aneurysms Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Bundang Hospital, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Second Military Medical University, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011-

List of Figures
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, G7 Countries (%), 2011-
Cerebral Aneurysms Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
GlobalData Methodology

Customers who bought this item also bought

• Cholangitis Global Clinical Trials Review, H1, 2013
• Strabismus Global Clinical Trials Review, H1, 2013
• Ulcers Global Clinical Trials Review, H1, 2013
• Alopecia Global Clinical Trials Review, H1, 2013
• Peptic Ulcers Global Clinical Trials Review, H2, 2012
• Cachexia Global Clinical Trials Review, H1, 2013
• Bronchitis Global Clinical Trials Review, H2, 2012
• Nasal Congestion Global Clinical Trials Review, H1, 2013
• Otitis Media Global Clinical Trials Review, H2, 2012
• Anal Fissure Global Clinical Trials Review, H1, 2013